Patient cases

The 4 different case studies below allow you to select appropriate treatment plans for each of these patients.* For each case, alternate plans are presented showing where STIVARGA® (regorafenib) might best fit for treatment of that patient.

STIVARGA® (regorafenib) patient Sandra


  • Meet Sandra:
  • Age 67
  • Stage IV rectal cancer
  • KRAS mutant
STIVARGA® (regorafenib) patient Kevin


  • Meet Kevin:
  • Age 64
  • Stage IV colon cancer
  • KRAS mutant
STIVARGA® (regorafenib) patient Hector


  • Meet Hector:
  • Age 61
  • Stage IV colon cancer (T4, N2, M1)
  • KRAS wild-type
STIVARGA® (regorafenib) patient Jane


  • Meet Jane:
  • Age 60
  • Stage IV recurrent colon cancer
  • KRAS wild-type